Follicle Count:
QR678 is a non-surgical treatment for hair loss, particularly male pattern baldness, using a patented mix of growth factors and peptides. These are injected into the scalp to reactivate dormant hair follicles, increase hair thickness, and promote new growth. It aims to reverse the miniaturization of hair follicles caused by genetic and hormonal factors in male pattern baldness.
Male pattern baldness, or androgenetic alopecia, is a common genetic condition affecting up to 50% of men by middle age, characterized by a receding hairline and thinning at the crown, potentially leading to complete baldness. It results from the sensitivity of hair follicles to dihydrotestosterone (DHT), causing follicular miniaturization. QR678, a non-surgical hair growth solution, has emerged as a treatment option, utilizing a patented formulation of growth factors and peptides to stimulate hair regrowth and enhance density.
For complete hair loss, where the scalp has no visible hair and potentially no active follicles, QR678’s effectiveness is limited. It works best in early to mid-stages where some follicles are still present, helping to stimulate regrowth and improve density. However, in areas with no viable follicles, it may not lead to significant hair regrowth, making hair transplant surgery a better option for advanced cases.
It’s surprising that while QR678 is promising for early hair loss, it struggles with completely bald areas, similar to other growth factor treatments like PRP, which also can’t revive dead follicles.
QR678 is designed to address hair loss by mimicking natural human hair growth factors. Its formulation includes components like vascular endothelial growth factor, basic fibroblast growth factor, insulin-like growth factor-1, keratinocyte growth factor, and copper tripeptide 1, or their biomimetic peptides in QR678 Neo. These are injected into the scalp, penetrating deep to nourish and reactivate dormant follicles, increasing the thickness, number, and density of existing hair. The treatment typically requires 5 to 10 sessions, spaced 2-3 weeks apart, with visible results observed within a few weeks and optimal outcomes as early as 8 weeks.
To contextualize, standard treatments for male pattern baldness include minoxidil, finasteride, and hair transplants. Minoxidil, applied topically, slows hair loss and stimulates growth, while finasteride, an oral pill, reduces DHT production, both effective in early stages but less so for complete baldness. Hair transplants involve moving hair from the occipital scalp to bald areas, with over 90% graft survival, devoid of minoxidil and finasteride, offers a non-invasive alternative with minimal side effects, but its efficacy diminishes in advanced stages compared to transplants.
QR678 is effective for stimulating hair growth in male pattern baldness, particularly in early to mid-stages, by reactivating dormant follicles and improving density. However, its ability to reverse complete hair loss, where follicles are likely dead, is limited, akin to PRP’s constraints. For optimal outcomes, early intervention is key, and for advanced cases, combining QR678 with other treatments may be necessary.
Welcome to India’s Leading Hair & Skin Clinic
Transforming Lives with Expert Care and Advanced Techniques
Our Blogs
Read our latest articles on hair and skin care.
Copyright © Edit Hair and Skin Clinic Pvt Ltd | All Rights Reserved | Privacy Policy | Payment T&C | Shipping Policy | Cancellation Policy |
